iBio announces production of biosimilar rituximab with its iBioLaunch technology pharmabiz.com ... production of biotherapeutic proteins and vaccine antigens in whole green plants has been used to produce a functional monoclonal antibody copy of rituximab, used in the medical treatment of lymphomas, autoimmune diseases, and transplant rejection. ... |
